Articulinx Inc.
articulinx.com — move through life
About Articulinx Inc.
Articulinx Inc. was a medical device company established in 2007 by Tom Hogendijk. Headquartered in Cupertino, California, the firm concentrated on developing solutions within the orthopedic sector, specifically for the upper limb extremities and small joints markets. The company's strategic focus was on addressing the treatment gap for patients with early-stage osteoarthritis, positioned between palliative care and major joint reconstruction surgery.
The core of Articulinx's offering was the development of implants and devices designed for the treatment of hand osteoarthritis. Its flagship product, the Articulinx CMC Spacer, was a minimally invasive implant. This device was engineered to be implanted under local anesthesia through a small incision, where it would function as a spacer to separate bones in joints where articular cartilage had degenerated. A key benefit of the procedure was its tissue-sparing and bone-preserving nature, which also allowed for the possibility of reversal if necessary.
The company's business model revolved around the development and eventual commercialization of these specialized surgical devices. Articulinx secured significant financial backing to advance its product development. Over its active years, the company successfully raised a total of $18.2 million. A notable funding event was a Series B round in April 2010, which brought in $10 million to continue the development of the CMC Spacer. The company also pursued intellectual property protection, with patent filings for technologies described as "Non-planar orthopedic implants and methods" and "Disc-shaped orthopedic devices."
Source: Dealroom company dataNews
Open roles
Articulinx Inc. in the Cupertino ecosystem
The Articulinx Inc. office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Articulinx Inc. on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Articulinx Inc. on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
